Related Experiment Videos
Treatment of mitral valve prolapse and panic disorder with metoprolol
P Zwanzger1, T Baghai, C Schule
1Department of Psychiatry, Ludwig Maximilian University, Nussbaumstrasse 7, 80336 Munich, Germany. zwanzger@psy.med.uni-muenchen.de
Abstract:
The prevalence of mitral valve prolapse (MVP) and panic disorder (PD) has been reported to range from 0-50% depending on the respective diagnostic manuals and described selection criteria. We report the case of a 44-year-old patient suffering from both panic disorder and mitral valve prolapse. While antidepressants did not result in any improvement of panic symptoms, a fast remission was achieved by treating the patient with metoprolol. This case report suggests that betablockers might represent a useful tool in the treatment of panic disorder and mitral valve prolapse.
Insights
Mitral valve prolapse and panic disorder can co-occur. Beta-blockers, like metoprolol, may effectively treat panic symptoms in patients with both conditions, offering rapid remission.
Area of Science:
- Cardiology
- Psychiatry
- Pharmacology
Background:
- Mitral valve prolapse (MVP) and panic disorder (PD) are conditions with variable reported prevalence.
- Co-occurrence of MVP and PD presents unique clinical challenges.
Observation:
- A case report details a 44-year-old patient with both panic disorder and mitral valve prolapse.
- The patient experienced no improvement in panic symptoms with antidepressant treatment.
Findings:
- Treatment with metoprolol, a beta-blocker, resulted in rapid remission of panic symptoms.
- This suggests a potential efficacy of beta-blockers in managing panic disorder, particularly in patients with MVP.
Implications:
- Beta-blockers may be a valuable therapeutic option for panic disorder, especially in comorbid MVP cases.
- Further research into beta-blocker mechanisms for panic symptom relief is warranted.